SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Innovex International, Inc. (INVX) trades at a trailing P/E of 21.7, forward P/E of 18.5. Trailing earnings yield is 4.61%, forward earnings yield 5.41%. PEG 1.10. Graham Number is $20.41.
Criteria proven by this page:
- VALUE (78/100, Pass) — P/E is below market average (21.7); earnings yield beats bond yields (4.61%).
- Forward P/E 18.5 (down from trailing 21.7) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.10 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 4.61% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 5.41% as earnings recover.
- Analyst consensus target $27.00 (+4.2% upside) — modest upside expected.
Overall SharesGrow Score: 72/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
78/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — INVX
Valuation Multiples
P/E (TTM)21.7
Forward P/E18.5
PEG Ratio1.10
Forward PEG1.10
P/B Ratio1.71
P/S Ratio1.85
EV/EBITDA8.5
Per Share Data
EPS (TTM)$1.21
Forward EPS (Est.)$1.40
Book Value / Share$15.33
Revenue / Share$14.18
FCF / Share$2.26
Yields & Fair Value
Earnings Yield4.61%
Forward Earnings Yield5.41%
Dividend Yield0.00%
Graham Number$20.41
SharesGrow IV$106.38 (+310.4%)
Analyst Target$27.00 (+4.2%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
6.0 |
-0.12 |
0.41 |
1.03 |
- |
| 2017 |
-5.5 |
0.03 |
0.43 |
1.22 |
- |
| 2018 |
-5.7 |
1.40 |
0.50 |
1.43 |
- |
| 2019 |
308.6 |
-3.03 |
0.49 |
1.28 |
- |
| 2020 |
-17.0 |
0.01 |
0.50 |
1.43 |
- |
| 2021 |
53.0 |
-0.40 |
2.89 |
1.77 |
- |
| 2022 |
3.6 |
0.00 |
0.89 |
0.48 |
- |
| 2023 |
7.2 |
-0.14 |
1.61 |
0.95 |
- |
| 2024 |
5.0 |
0.14 |
0.73 |
1.05 |
10.79% |
| 2025 |
18.1 |
-0.32 |
1.43 |
1.54 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.47 |
$538.73M |
$93.22M |
17.3% |
| 2017 |
$-2.69 |
$455.47M |
$-100.64M |
-22.1% |
| 2018 |
$-2.58 |
$384.63M |
$-95.7M |
-24.9% |
| 2019 |
$0.05 |
$414.81M |
$1.72M |
0.4% |
| 2020 |
$-0.87 |
$364.97M |
$-30.77M |
-8.4% |
| 2021 |
$0.28 |
$294.84M |
$9.85M |
3.3% |
| 2022 |
$1.85 |
$467.19M |
$63.28M |
13.5% |
| 2023 |
$2.14 |
$424.06M |
$73.93M |
17.4% |
| 2024 |
$2.77 |
$660.8M |
$140.33M |
21.2% |
| 2025 |
$1.20 |
$978.25M |
$83.3M |
8.5% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.40 |
$1.40 – $1.40 |
$1B |
$1B – $1B |
1 |
| 2027 |
$1.82 |
$1.82 – $1.82 |
$1.08B |
$1.08B – $1.08B |
1 |
| 2028 |
$1.97 |
$1.97 – $1.97 |
$1.08B |
$1.08B – $1.08B |
1 |
